TROMSØ, NORWAY: ArcticZymes Technologies (OSE:AZT) announced the nomination of Dr. Frank Mathias as the new Chairman of the Board. Dr. Mathias is the CEO at Oxford Biomedica, a leading pure-play CDMO within the cell and gene therapy industry. Dr. Mathias…
TROMSØ: ArcticZymes Technologies ASA (AZT) has today entered into a Share Purchase Agreement (SPA) with Lallemand Inc’s subsidiary, Danstar Ferment AG for the divestment of AZT’s Biotec BetaGlucans AS subsidiary (BBG), a news release said· The transaction is based on…
TROMSØ: Biotec Pharmacon announced it has officially rebranded to ArcticZymes Technologies. As previously announced and decided by the Annual General Meeting, Biotec Pharmacon ASA has formally changed its name to ArcticZymes Technologies ASA. The new name is formally registered with…